U.S. Water Utilities Stock News

Pinnacle Financial Partners (PNFP) has followed up its Q1 2026 update with a solid run of recent numbers, capped by Q4 2025 revenue of US$508.1 million and basic EPS of US$2.16, supported by trailing 12 month EPS of US$8.15 on revenue of US$1.95 billion. Over the last year, revenue has moved from US$1.62 billion to US$1.95 billion on a trailing 12 month basis, while EPS has stepped up from US$6.01 to US$8.15, which may encourage investors to focus on how resilient margins and profit quality...

Why ProPetro Holding Is Back on Investors’ Radar ProPetro Holding (PUMP) moved higher after Halliburton’s stronger than expected first quarter profits lifted sector sentiment, while the company’s free cash flow generation and PROPWR investments kept attention on its underlying business. See our latest analysis for ProPetro Holding. That sector-wide boost has arrived on top of a strong run in ProPetro’s own stock, with a 90 day share price return of 53.84% and a one year total shareholder...

In recent days, Antero Resources drew attention as analysts highlighted the company as a growth-at-a-reasonable-price opportunity in Appalachian natural gas and liquids, while also anticipating higher year-over-year earnings and revenue for the March 2026 quarter. At the same time, several research firms reiterated positive views on the business, citing stronger LPG pricing and weather-driven demand as supportive factors ahead of its upcoming results. We’ll now examine how this wave of...

Acadia Healthcare Company (NasdaqGS:ACHC) has appointed David Duckworth as Interim CFO, replacing outgoing CFO Todd Young. Duckworth returns to the role after nearly a decade of prior service as Acadia's CFO. The transition occurs while the company continues its search for a permanent CEO. Acadia Healthcare shares recently closed at $27.34, with the stock up 20.5% over the past 30 days and 1.7% over the past week. Over a longer horizon, returns have been mixed, with a 91.3% return year to...

Recent performance context for Novo Nordisk Novo Nordisk (NYSE:NVO) has been trading around $38.52, with a 1 day return of about 1.6% and a past week move near 5.9%, as investors weigh its broader performance trends. See our latest analysis for Novo Nordisk. While the recent 7 day share price return of about 5.9% contrasts with a 90 day share price return of roughly 38% and a 1 year total shareholder return of around 36%, the pattern points to fading momentum after a stronger stretch earlier...

In mid-April 2026, Magnite announced expanded collaborations with Hearst News and AMC Global Media to power high-impact web, CTV, and live-streaming ad formats using its SpringServe, ClearLine, and Live Scheduler platforms. These partnerships highlight how Magnite is embedding its technology deeper into premium news and entertainment ecosystems, giving advertisers streamlined access to large, highly engaged audiences across linear TV, streaming, and digital video. Next, we’ll examine how...

Kohl's recently disclosed that it will receive a US$550 million refund for tariffs it had previously paid, providing a one-time boost to its reported revenue and earnings. This unexpected tariff refund arrives against a backdrop of earlier guidance for weaker earnings and softer sales, materially improving Kohl's near-term financial flexibility. Next, we’ll examine how this sizable tariff refund reshapes Kohl’s investment narrative, including its margin outlook and balance sheet...

Why Equifax’s latest quarter is drawing investor attention Equifax (EFX) is back in focus after reporting first quarter 2026 results that exceeded earlier guidance, with revenue up 14% year on year and solid contributions from U.S. mortgage and Workforce Solutions. See our latest analysis for Equifax. Despite the strong first quarter update and ongoing share repurchases, Equifax’s 1 year total shareholder return of 31.37% and year to date share price return of 18.27% indicate pressure on...

What recent performance says about American Water Works Company American Water Works Company (AWK) has drawn investor attention after a recent share price move, with the stock up about 3% over the past week and roughly 1% over the past month. That follows a year where the total return sits near a 5% decline, even as year-to-date performance is about 3.6% and the past 3 months show roughly a 4.1% gain, prompting closer scrutiny of fundamentals. See our latest analysis for American Water Works...

ImmunityBio (IBRX) is back in focus after announcing that ANKTIVA is now commercially available in Saudi Arabia for approved bladder and metastatic lung cancer uses. This development marks another step in the therapy’s international rollout. See our latest analysis for ImmunityBio. The share price has reacted strongly to this stream of approvals and the Saudi launch, with a 12.97% 7 day share price return and a very large year to date share price gain. At the same time, the 5 year total...

Wondering whether Webull's share price reflects its true worth, or if the market is mispricing it? This article walks through the key valuation angles you need to see for yourself. Webull's stock last closed at US$6.91, with returns of 6.6% over the past week and 34.7% over the past month, while the 1 year return sits at a loss of 64.6%. Recent headlines around Webull have focused on the stock's sharp swings and what that might imply for investor sentiment and risk appetite. These moves put...

TG Therapeutics recently completed enrollment in a Phase 3 trial of a subcutaneous formulation of BRIUMVI for adults with relapsing multiple sclerosis, comparing every 8- and 12-week dosing to the currently approved intravenous regimen on pharmacokinetics, safety, and clinical outcomes. A key focus of the study is whether subcutaneous BRIUMVI can match the drug exposure of the intravenous form while potentially offering a more convenient administration schedule and expanding its clinical...

W. R. Berkley (NYSE:WRB) has appointed R. Christopher DeLauder as president of Berkley Environmental. The move reflects an internal promotion within a key specialty unit focused on environmental insurance. The leadership change signals a new point person for underwriting, risk focus, and execution inside this subsidiary. The appointment at Berkley Environmental comes as W. R. Berkley shares trade around $68.45, with returns of 3.3% over the past week and 5.3% over the past month. Over a...

Wondering if Sterling Infrastructure at around US$495.67 is priced for perfection or still offers value? This article focuses squarely on what that share price could mean for you. The stock has posted returns of 12.4% over 7 days, 11.1% over 30 days, 55.3% year to date and 239.5% over 1 year, with very large gains over 3 and 5 years. Recent coverage has highlighted Sterling Infrastructure’s role in US construction and infrastructure projects, along with growing investor attention to...

Synchrony Financial (NYSE:SYF) has rolled out a co-branded credit card and digital loyalty suite with Chico's, White House Black Market, and Soma. The launch introduces a unified rewards ecosystem across the Chico's FAS brands, focused on women's apparel and lifestyle shoppers. The new products use Synchrony’s PRISM credit decisioning technology to support both in store and digital customer experiences. For investors watching NYSE:SYF, this move comes as the shares trade at $76.62, with a 1...

Why Agnico Eagle Mines is on investors’ radar today Agnico Eagle Mines (NYSE:AEM) is back in focus after recent share price swings, with a 1 day return of 2.5% decline contrasted with a month gain of 8.4% and a past 3 months decline of 7.3%. For investors watching gold producers, that mixed return profile sits alongside reported annual revenue of US$11.91b and net income of US$4.46b, providing a sense of the company’s current scale and profitability. See our latest analysis for Agnico Eagle...

Nurix Therapeutics (NRIX) put its oncology pipeline in focus at the AACR 2026 Annual Meeting, releasing new preclinical data on its pan mutant BRAF, CBL B, and Aurora Kinase A degrader programs. See our latest analysis for Nurix Therapeutics. Nurix’s latest AACR data drop comes after a mixed share price run, with a 14.75% 1 month share price return but a 1 year to date share price decline of 8.25%, while the 1 year total shareholder return sits at 43.84%, hinting at shifting expectations...

Adams Diversified Equity Fund, Inc. recently declared a higher distribution of US$0.48 per share, payable on May 29, 2026 to shareholders of record on April 27, 2026. This increased payout underscores the fund’s current emphasis on returning cash to investors through distributions, an important consideration for income-focused portfolios. Next, we will examine how this higher distribution influences Adams Diversified Equity Fund’s investment narrative, particularly for investors prioritizing...

NIO's chip move and why it matters for shareholders NIO (NYSE:NIO) is drawing attention after CEO William Li confirmed the company is developing its own automotive chips, aiming to cut reliance on suppliers like Nvidia and better match its AI centric vehicle systems. See our latest analysis for NIO. That chip announcement comes in a mixed price backdrop, with the share price at US$6.28 after a 3.1% one day decline and an 8.6% seven day setback, while a 35.3% 90 day share price return and...

If you are wondering whether Charter Communications at around US$241.78 is pricing in too much pessimism or quiet value, the stock's recent history gives you a lot to chew on. The share price has returned 2.5% over the last 7 days and 11.1% over 30 days, while year to date it is up 15.5% but still shows a 27.9% decline over 1 year and a 63.9% decline over 5 years. Recent coverage has focused on how Charter sits within the broader US media space, with investors weighing cable and broadband...

Context for Trinity Capital after recent share performance Trinity Capital (TRIN) has seen mixed share performance lately, with a 2.7% decline over the past day, a small pullback over the past week, and a gain over the past month. Across longer periods the picture is also uneven, with a 5.6% decline over the past 3 months, a modest positive return year to date, and a stronger total return over the past year and multi year periods. See our latest analysis for Trinity Capital. With the share...

Wondering whether COMPASS Pathways at around US$9.15 still stacks up on value or has run ahead of itself? This article breaks down what the recent moves might mean for you as an investor. The stock has recently shown strong momentum, with returns of 37.4% over 7 days, 75.3% over 30 days, 39.7% year to date and 129.3% over 1 year, while the 3 year return sits at 13.2% and the 5 year return at a loss of 76.5%. These swings have come as COMPASS Pathways continues to sit in the spotlight of...

If you are wondering whether Ardelyx at around US$5.96 is priced attractively or not, the key question is how that tag compares with what the business might reasonably be worth. The stock has been volatile recently, with a 5.1% decline over the last 7 days, an 11.4% gain over 30 days, a 3.1% decline year to date, and an 18.7% return over the past year, which may signal changing views on its potential and risk. Recent headlines around Ardelyx have focused on its place in the biotech space and...

Old Second Bancorp (OSBC) opened Q1 2026 earnings season with Q4 2025 revenue of US$92.2 million, basic EPS of US$0.55 and net income of US$28.8 million, setting the tone for how you might assess the latest numbers against its recent track record. Over the past year, revenue has moved from US$69.7 million in Q4 2024 to US$92.2 million in Q4 2025, while trailing twelve month EPS came in at US$1.64 alongside a 25.8% net profit margin. This points to earnings power but also hints at some margin...